Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
501651
Reference Type
Journal Article
Subtype
Review
Title
Paraneoplastic neurological syndromes and breast cancer. Regression of paraneoplastic neurological sensorimotor neuropathy in a patient with metastatic breast cancer treated with capecitabine: a case study and mini-review of the literature
Author(s)
Minisini, AM; Pauletto, G; Bergonzi, P; Fasola, G
Year
2007
Is Peer Reviewed?
Yes
Journal
Breast Cancer Research and Treatment
ISSN:
0167-6806
EISSN:
1573-7217
Volume
105
Issue
2
Page Numbers
133-138
Language
English
DOI
10.1007/s10549-006-9444-0
Abstract
Paraneoplastic neurological syndromes are a rare complication of breast cancer. Nevertheless, they may be clinically relevant leading to neurological impairment. Clinicians should be aware that these neurological disorders could even precede the diagnosis of breast cancer. Here we present the case of a female patient with advanced breast cancer who developed paraneoplastic sensorimotor neuropathy. Treatment with capecitabine lead to clinical amelioration. A review of the literature on the paraneoplastic neurological syndromes in breast cancer is also included.
Keywords
neurological paraneoplastic syndrome; autoantibodies; sensorimotor; neuropathy; breast cancer; capecitabine; primary lateral sclerosis; cerebellar degeneration; peripheral; neuropathy; diagnostic-criteria; retinopathy; antibodies; disorders; features
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity